SlideShare a Scribd company logo
1 of 11
BBMRI  Expert Centres K. Zatloukal Medical University of Graz, Austria Stakeholder Meeting Paris, December 15th 2009
BBMRI Expert Centres ,[object Object]
Why Expert Centres? ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Access by the Industry ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Patient‘s Sample Med. data Industry Scientific collaboration Cost recovery Problem if no scientific collaboration is possible since financial compensation  is no reasonable incentive for contributors and not accepted by public Samples Med. data Patient
Expert Centers: Model A Hospital Patients Biobank Expert Centers Industry Samples  Med. data Expertise Cost recov. Samples  Med. data Expertise Data Cost recov. Research data Expertise In-kind Cost recov. Public  (not-for-profit) Private – competitive (for-profit) Provides efficient access to samples, data and expertise Mutual benefit from expertise and in-kind contributions Reduces requirements for sample shipment  Gateway for global collaborations Public-Private pre-competitive (not-for-profit)
Expert Centers: Model B Hospital Patients Biobank Expert Centers Industry Samples  Med. data Expertise Data Cost recov. Samples  Med. data Expertise Data Cost recov. Research data Expertise In-kind Cost recov. Public  (not-for-profit) Private – competitive (for-profit) Provides efficient access to samples, data and expertise Mutual benefit from expertise and in-kind contributions Reduces requirements for sample shipment  Gateway for global collaborations
Expert Centers: Model C Hospital Patients Biobank Expert Centers Industry Samples  Med. data Expertise Cost recov. Samples  Med. data Expertise Cost recov. Processed samples Expertise Cost recov. Public  (not-for-profit) Private – competitive (for-profit) Provides efficient access to samples, data and expertise Reduces requirements for raw sample shipment
Expert Centers Features ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Global Integration of BBMRI by Implementation of the OECD GBRCN Concept in Europe
Expert Centres as Highways for  Transnational Research Collaborations Samples Medical Data Europe Biological Resource Centre Expert Centre China Biological Resource Centre Expert Centre Research Data Samples Medical Data Samples Medical data
[object Object],[object Object],Thank you

More Related Content

What's hot

Report on requirements and expectations survey
Report on requirements and expectations surveyReport on requirements and expectations survey
Report on requirements and expectations surveyBlue BRIDGE
 
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...DRIVE research
 
1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...chronaki
 
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurGovernance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurDRIVE research
 
The HTAi Vortal: a comparative analysis
The HTAi Vortal: a comparative analysisThe HTAi Vortal: a comparative analysis
The HTAi Vortal: a comparative analysisPatrice Chalon
 
Interoperability Assets for Patient Summary Components: a Gap Analysis
Interoperability Assets for Patient Summary Components: a Gap AnalysisInteroperability Assets for Patient Summary Components: a Gap Analysis
Interoperability Assets for Patient Summary Components: a Gap AnalysisAnnaSeebergHansen
 
Supporting a national funders open access policy (Portugal)
Supporting a national funders open access policy (Portugal)Supporting a national funders open access policy (Portugal)
Supporting a national funders open access policy (Portugal)OpenAIRE
 
Linda kahl openmta an option for dissemination of giab samples
Linda kahl openmta an option for dissemination of giab samplesLinda kahl openmta an option for dissemination of giab samples
Linda kahl openmta an option for dissemination of giab samplesGenomeInABottle
 
Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...
Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...
Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...Pistoia Alliance
 
Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020
Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020
Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020Sean Ekins
 
Research & Innovation Strategies at Hospital Clínic
Research & Innovation  Strategies at Hospital ClínicResearch & Innovation  Strategies at Hospital Clínic
Research & Innovation Strategies at Hospital ClínicBarcelona Empresa
 
Tarun_Jain_Resume-2016
Tarun_Jain_Resume-2016Tarun_Jain_Resume-2016
Tarun_Jain_Resume-2016Tarun Jain
 
1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...chronaki
 
Introduction to DRIVE - Javier Diez Domingo
Introduction to DRIVE - Javier Diez DomingoIntroduction to DRIVE - Javier Diez Domingo
Introduction to DRIVE - Javier Diez DomingoDRIVE research
 
C like business model 20160901 update
C like business model  20160901 updateC like business model  20160901 update
C like business model 20160901 updateCheng Han-Ni
 
Edit Grogh - Open Peer Review in OpenUP | OpenUP Final Conference
Edit Grogh - Open Peer Review in OpenUP | OpenUP Final ConferenceEdit Grogh - Open Peer Review in OpenUP | OpenUP Final Conference
Edit Grogh - Open Peer Review in OpenUP | OpenUP Final ConferenceOpenUP project
 
Developments in Clinical Trials
Developments in Clinical TrialsDevelopments in Clinical Trials
Developments in Clinical TrialsMichael Passanante
 

What's hot (20)

Cerem
CeremCerem
Cerem
 
Report on requirements and expectations survey
Report on requirements and expectations surveyReport on requirements and expectations survey
Report on requirements and expectations survey
 
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
Roundtable discussion: Relevance of the DRIVE study platform and sustainabili...
 
1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...
 
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi PasteurGovernance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur
 
The HTAi Vortal: a comparative analysis
The HTAi Vortal: a comparative analysisThe HTAi Vortal: a comparative analysis
The HTAi Vortal: a comparative analysis
 
Interoperability Assets for Patient Summary Components: a Gap Analysis
Interoperability Assets for Patient Summary Components: a Gap AnalysisInteroperability Assets for Patient Summary Components: a Gap Analysis
Interoperability Assets for Patient Summary Components: a Gap Analysis
 
Making Natural Product Research Work: The Importance of Collaborations and IP
Making Natural Product Research Work: The Importance of Collaborations and IPMaking Natural Product Research Work: The Importance of Collaborations and IP
Making Natural Product Research Work: The Importance of Collaborations and IP
 
Supporting a national funders open access policy (Portugal)
Supporting a national funders open access policy (Portugal)Supporting a national funders open access policy (Portugal)
Supporting a national funders open access policy (Portugal)
 
Linda kahl openmta an option for dissemination of giab samples
Linda kahl openmta an option for dissemination of giab samplesLinda kahl openmta an option for dissemination of giab samples
Linda kahl openmta an option for dissemination of giab samples
 
Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...
Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...
Collaborative Drug Discovery -- Life Science Collaboration & Virtualization: ...
 
Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020
Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020
Pistoia Pharma-in-a box: A vision for virtualized pharma in 2020
 
CTI Landing Page
CTI Landing PageCTI Landing Page
CTI Landing Page
 
Research & Innovation Strategies at Hospital Clínic
Research & Innovation  Strategies at Hospital ClínicResearch & Innovation  Strategies at Hospital Clínic
Research & Innovation Strategies at Hospital Clínic
 
Tarun_Jain_Resume-2016
Tarun_Jain_Resume-2016Tarun_Jain_Resume-2016
Tarun_Jain_Resume-2016
 
1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...1st eStandards conference: next steps for standardization in large scale eHea...
1st eStandards conference: next steps for standardization in large scale eHea...
 
Introduction to DRIVE - Javier Diez Domingo
Introduction to DRIVE - Javier Diez DomingoIntroduction to DRIVE - Javier Diez Domingo
Introduction to DRIVE - Javier Diez Domingo
 
C like business model 20160901 update
C like business model  20160901 updateC like business model  20160901 update
C like business model 20160901 update
 
Edit Grogh - Open Peer Review in OpenUP | OpenUP Final Conference
Edit Grogh - Open Peer Review in OpenUP | OpenUP Final ConferenceEdit Grogh - Open Peer Review in OpenUP | OpenUP Final Conference
Edit Grogh - Open Peer Review in OpenUP | OpenUP Final Conference
 
Developments in Clinical Trials
Developments in Clinical TrialsDevelopments in Clinical Trials
Developments in Clinical Trials
 

Viewers also liked (10)

Kurt Zatloukal
Kurt ZatloukalKurt Zatloukal
Kurt Zatloukal
 
Jasper Bovenberg
Jasper BovenbergJasper Bovenberg
Jasper Bovenberg
 
Paula Kim
Paula KimPaula Kim
Paula Kim
 
Patient Partner
Patient PartnerPatient Partner
Patient Partner
 
Cees Smit
Cees SmitCees Smit
Cees Smit
 
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal PathwaysBioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
BioSHaRE: The BBMRI-ERIC ELSI Services - Jasper Bovenberg - Legal Pathways
 
Fair Access: a practical approach to policy on access for European biobanking
Fair Access: a practical approach to policy on access for European biobankingFair Access: a practical approach to policy on access for European biobanking
Fair Access: a practical approach to policy on access for European biobanking
 
Emmanuelle Rial
Emmanuelle RialEmmanuelle Rial
Emmanuelle Rial
 
Technopolis
TechnopolisTechnopolis
Technopolis
 
Beta Report
Beta ReportBeta Report
Beta Report
 

Similar to Kurt Zatloukal

Expert C Kurt Zatloukal 16 Dec 09 Ok
Expert C Kurt Zatloukal 16 Dec 09 OkExpert C Kurt Zatloukal 16 Dec 09 Ok
Expert C Kurt Zatloukal 16 Dec 09 Okguest80d4e3cc
 
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HxRefactored
 
Research Cytogenetic Lab Presentation
Research Cytogenetic Lab PresentationResearch Cytogenetic Lab Presentation
Research Cytogenetic Lab PresentationErik Goodfriend
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenMats Sundgren
 
Business-led Translation A presentation by CEO, Keith Thompson, about growing...
Business-led Translation A presentation by CEO, Keith Thompson, about growing...Business-led Translation A presentation by CEO, Keith Thompson, about growing...
Business-led Translation A presentation by CEO, Keith Thompson, about growing...Cell and Gene Therapy Catapult
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleHadas Jacoby
 
Liquilume NSF Final Presentation
Liquilume NSF Final PresentationLiquilume NSF Final Presentation
Liquilume NSF Final PresentationStanford University
 
UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017Nathalie Kopecky
 
Translating Cell Therapies: Academic versus Industry model
Translating Cell Therapies: Academic versus Industry modelTranslating Cell Therapies: Academic versus Industry model
Translating Cell Therapies: Academic versus Industry modelnanog
 
Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016Mats Sundgren
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalHidee Cyd
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedStanford University
 
EuroBioForum 2013 - Day 2 | Frank Molina
 EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank MolinaEuroBioForum
 
KCR: Cost effectiveness in clinical trials
KCR: Cost effectiveness in clinical trialsKCR: Cost effectiveness in clinical trials
KCR: Cost effectiveness in clinical trialsKCR
 
BravoConnect 2014: Spend Analytics & Benchmarking
BravoConnect 2014: Spend Analytics & BenchmarkingBravoConnect 2014: Spend Analytics & Benchmarking
BravoConnect 2014: Spend Analytics & BenchmarkingBravoSolution
 
ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF Hannah Eherenfeldt
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenGBX Events
 
Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...Antti Haapalinna
 

Similar to Kurt Zatloukal (20)

Expert C Kurt Zatloukal 16 Dec 09 Ok
Expert C Kurt Zatloukal 16 Dec 09 OkExpert C Kurt Zatloukal 16 Dec 09 Ok
Expert C Kurt Zatloukal 16 Dec 09 Ok
 
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
HXR 2016: Tracking the Body: Devices, Consumer Genomics, and Sensors- Aymen E...
 
Mbis Presentation University
Mbis Presentation  UniversityMbis Presentation  University
Mbis Presentation University
 
Research Cytogenetic Lab Presentation
Research Cytogenetic Lab PresentationResearch Cytogenetic Lab Presentation
Research Cytogenetic Lab Presentation
 
Evoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_SundgrenEvoulution Summit_November_2015_Sundgren
Evoulution Summit_November_2015_Sundgren
 
Business-led Translation A presentation by CEO, Keith Thompson, about growing...
Business-led Translation A presentation by CEO, Keith Thompson, about growing...Business-led Translation A presentation by CEO, Keith Thompson, about growing...
Business-led Translation A presentation by CEO, Keith Thompson, about growing...
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
Liquilume NSF Final Presentation
Liquilume NSF Final PresentationLiquilume NSF Final Presentation
Liquilume NSF Final Presentation
 
UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017UoB Business Club Breakfast Briefing - November 2017
UoB Business Club Breakfast Briefing - November 2017
 
Translating Cell Therapies: Academic versus Industry model
Translating Cell Therapies: Academic versus Industry modelTranslating Cell Therapies: Academic versus Industry model
Translating Cell Therapies: Academic versus Industry model
 
Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016Global Discovery & Developement Innovation Forum 29016
Global Discovery & Developement Innovation Forum 29016
 
Diagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA finalDiagnostics Market Disruption HIDA final
Diagnostics Market Disruption HIDA final
 
Altuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons LearnedAltuna Engr245 2022 Lessons Learned
Altuna Engr245 2022 Lessons Learned
 
Company presentation 2013
Company presentation 2013Company presentation 2013
Company presentation 2013
 
EuroBioForum 2013 - Day 2 | Frank Molina
 EuroBioForum 2013 - Day 2 | Frank Molina EuroBioForum 2013 - Day 2 | Frank Molina
EuroBioForum 2013 - Day 2 | Frank Molina
 
KCR: Cost effectiveness in clinical trials
KCR: Cost effectiveness in clinical trialsKCR: Cost effectiveness in clinical trials
KCR: Cost effectiveness in clinical trials
 
BravoConnect 2014: Spend Analytics & Benchmarking
BravoConnect 2014: Spend Analytics & BenchmarkingBravoConnect 2014: Spend Analytics & Benchmarking
BravoConnect 2014: Spend Analytics & Benchmarking
 
ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF ReSuture Pitch Deck Demo Day PDF
ReSuture Pitch Deck Demo Day PDF
 
DEC 3 2015 Mats Sundgren
DEC 3 2015 Mats SundgrenDEC 3 2015 Mats Sundgren
DEC 3 2015 Mats Sundgren
 
Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...Views for collaboration between pharmaceutical industry and academia a haapal...
Views for collaboration between pharmaceutical industry and academia a haapal...
 

More from BBMRI Stakeholder's Forum (11)

Eero Vuorio
Eero VuorioEero Vuorio
Eero Vuorio
 
Thomas Meitinger
Thomas MeitingerThomas Meitinger
Thomas Meitinger
 
Neil Formstone
Neil FormstoneNeil Formstone
Neil Formstone
 
Eero Vuorio
Eero  VuorioEero  Vuorio
Eero Vuorio
 
Fabrizia Bignami
Fabrizia  BignamiFabrizia  Bignami
Fabrizia Bignami
 
International Biobanking: Oportunities and Challenges for Private-Public Coll...
International Biobanking: Oportunities and Challenges for Private-Public Coll...International Biobanking: Oportunities and Challenges for Private-Public Coll...
International Biobanking: Oportunities and Challenges for Private-Public Coll...
 
Georges Dagher
Georges DagherGeorges Dagher
Georges Dagher
 
Markus Perola
Markus PerolaMarkus Perola
Markus Perola
 
Julie Corfield
Julie CorfieldJulie Corfield
Julie Corfield
 
Jean Emmanuel Faure
Jean Emmanuel FaureJean Emmanuel Faure
Jean Emmanuel Faure
 
Biobanks: Patients’ Role and Expectations
Biobanks: Patients’ Role and ExpectationsBiobanks: Patients’ Role and Expectations
Biobanks: Patients’ Role and Expectations
 

Recently uploaded

Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)wesley chun
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CVKhem
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWERMadyBayot
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProduct Anonymous
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...apidays
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfOverkill Security
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024The Digital Insurer
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...Zilliz
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdflior mazor
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?Igalia
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusZilliz
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerThousandEyes
 
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...apidays
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...Martijn de Jong
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxRustici Software
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MIND CTI
 

Recently uploaded (20)

Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 
Real Time Object Detection Using Open CV
Real Time Object Detection Using Open CVReal Time Object Detection Using Open CV
Real Time Object Detection Using Open CV
 
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWEREMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
EMPOWERMENT TECHNOLOGY GRADE 11 QUARTER 2 REVIEWER
 
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemkeProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
ProductAnonymous-April2024-WinProductDiscovery-MelissaKlemke
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...Apidays New York 2024 - The value of a flexible API Management solution for O...
Apidays New York 2024 - The value of a flexible API Management solution for O...
 
Ransomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdfRansomware_Q4_2023. The report. [EN].pdf
Ransomware_Q4_2023. The report. [EN].pdf
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ..."I see eyes in my soup": How Delivery Hero implemented the safety system for ...
"I see eyes in my soup": How Delivery Hero implemented the safety system for ...
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
A Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source MilvusA Beginners Guide to Building a RAG App Using Open Source Milvus
A Beginners Guide to Building a RAG App Using Open Source Milvus
 
How to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected WorkerHow to Troubleshoot Apps for the Modern Connected Worker
How to Troubleshoot Apps for the Modern Connected Worker
 
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
Apidays Singapore 2024 - Scalable LLM APIs for AI and Generative AI Applicati...
 
2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...2024: Domino Containers - The Next Step. News from the Domino Container commu...
2024: Domino Containers - The Next Step. News from the Domino Container commu...
 
Corporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptxCorporate and higher education May webinar.pptx
Corporate and higher education May webinar.pptx
 
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law DevelopmentsTrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
TrustArc Webinar - Stay Ahead of US State Data Privacy Law Developments
 
MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024MINDCTI Revenue Release Quarter One 2024
MINDCTI Revenue Release Quarter One 2024
 

Kurt Zatloukal

  • 1. BBMRI Expert Centres K. Zatloukal Medical University of Graz, Austria Stakeholder Meeting Paris, December 15th 2009
  • 2.
  • 3.
  • 4.
  • 5. Expert Centers: Model A Hospital Patients Biobank Expert Centers Industry Samples Med. data Expertise Cost recov. Samples Med. data Expertise Data Cost recov. Research data Expertise In-kind Cost recov. Public (not-for-profit) Private – competitive (for-profit) Provides efficient access to samples, data and expertise Mutual benefit from expertise and in-kind contributions Reduces requirements for sample shipment Gateway for global collaborations Public-Private pre-competitive (not-for-profit)
  • 6. Expert Centers: Model B Hospital Patients Biobank Expert Centers Industry Samples Med. data Expertise Data Cost recov. Samples Med. data Expertise Data Cost recov. Research data Expertise In-kind Cost recov. Public (not-for-profit) Private – competitive (for-profit) Provides efficient access to samples, data and expertise Mutual benefit from expertise and in-kind contributions Reduces requirements for sample shipment Gateway for global collaborations
  • 7. Expert Centers: Model C Hospital Patients Biobank Expert Centers Industry Samples Med. data Expertise Cost recov. Samples Med. data Expertise Cost recov. Processed samples Expertise Cost recov. Public (not-for-profit) Private – competitive (for-profit) Provides efficient access to samples, data and expertise Reduces requirements for raw sample shipment
  • 8.
  • 9. Global Integration of BBMRI by Implementation of the OECD GBRCN Concept in Europe
  • 10. Expert Centres as Highways for Transnational Research Collaborations Samples Medical Data Europe Biological Resource Centre Expert Centre China Biological Resource Centre Expert Centre Research Data Samples Medical Data Samples Medical data
  • 11.